Perlegen Sciences, Inc. Files to Withdraw $115 Million IPO

WASHINGTON, May 1 (Reuters) - Biopharmaceutical company Perlegen Sciences Inc. filed with regulators on Tuesday to withdraw its plans to raise up to $115 million in an initial public offering of common stock.

>>> Discuss This Story

Back to news